KRASG12D inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8+ T cellsKrishnan K. Mahadevan, Raghu Kalluri|Cancer Cell|2023Cited by 219
Elimination of oncogenic KRAS in genetic mouse models eradicates pancreatic cancer by inducing FAS-dependent apoptosis by CD8+ T cellsKrishnan K. Mahadevan, Raghu Kalluri|Developmental Cell|2023Cited by 64